Oral tolerance as therapy for experimental autoimmune encephalomyelitis and multiple sclerosis: Demonstration of T cell anergy

Immunology and Cell Biology

Volumn 76, Issue 1, 1998, Pages 74-82

  Jewell, Scott D ^a,b   Gienapp, Ingrid E ^a   Cox, Karen L ^a   Whitacre, Caroline C ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b Medical Research Facility   (United States)

Author keywords

Anergy; Experimental autoimmune encephalomyelitis; Multiple sclerosis; Oral tolerance; T cell

Indexed keywords

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ARTICLE; CLONAL ANERGY; HELPER CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; MALE; MULTIPLE SCLEROSIS; NONHUMAN; RAT; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

EID: 0031946010     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1711.1998.00716.x     Document Type: Article

References (45)

1. Bitar DM, Whitacre CC. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. Cell. Immunol. 1988; 112: 364-70.
2. Higgins PJ, Weiner HL. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments. J. Immunol. 1988; 140: 440-5.
3. Fuller KA, Pearl D, Whitacre CC. Oral tolerance in experimental autoimmune encephalomyelitis: Serum and salivary antibody responses. J. Neuroimmunol. 1990; 28: 15-26.
4. Meyer AL, Benson JM, Gienapp IE, Cox KL, Whitacre CC. Suppression of murine chronic relapsing experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. J. Immunol. 1996; 157: 4230-8.
5. + T lymphocytes. J. Immunol. 1989; 142: 748-52.
6. + T cells are required for the induction of oral tolerance. Int. Immunol. 1995; 7: 501-4.
7. Weiner HL, Friedman A, Miller A et al. Oral tolerance: Immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu. Rev. Immunol. 1994; 12: 809-37.
8. 2 cells by feeding ovalbumin. Ann. NY Acad. Sci. 1996; 778: 122-32.
9. Whitacre CC, Gienapp IE, Orosz CG, Bitar D. Oral tolerance in experimental autoimmune encephalomyelitis. III: Evidence for clonal anergy. J. Immunol. 1991; 147: 2155-63.
10. Webb S, Morris C, Sprent J. Extrathymic tolerance of mature T cells: Clonal elimination as a consequence of immunity. Cell 1990; 63: 1249-50.
11. Chen YH, Inobe JI, Marks R, Gonnella P, Kuchroo VK, Weiner HL. Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature 1995; 376: 177-9.
12. Chen YH, Weiner HL. Dose-dependent activation and deletion of antigen-specific T cells following oral tolerance. Ann. NY Acad. Sci. 1996; 778: 111-21.
13. Friedman A, Weiner HL. Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc. Natl Acad. Sci. USA 1994; 91: 6688-92.
14. Melamed D, Friedman A. Direct evidence for anergy in T lymphocytes tolerized by oral administration of ovalbumin. Eur. J. Immunol. 1993; 23: 935-42.
15. Whitacre CC, Gienapp IE, Cox KL, Javed N. Oral tolerance in experimental autoimmune encephalomyelitis. Ann. NY Acad. Sci. 1996; 778: 217-27.
16. Khoury SJ, Hancock WW, Weiner HL. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with down-regulation of inflammatory cytokines and different in upregulation of transforming growth factor β interleukin 4 and prostaglandin E expression in the brain. J. Exp Med. 1992; 176: 1355-64.
17. Chen YH, Kuchroo VK, Inobe JI, Hafler DA, Weiner HL. Regulatory T cell clones induced by oral tolerance: Suppression of autoimmune encephalomyelitis. Science 1994; 265: 1237-40.
18. Fishman-Lobell J, Freidman A, Weiner HL. Different kinetic patterns of cytokine gene expression in vivo in orally tolerant mice. Eur. J. Immunol. 1994; 24: 2720-4.
19. 2 cells are subject to high dose oral tolerance and are not essential for its induction. J. Immunol. 1995; 154: 3549-55.
20. Schwartz RH. A cell culture model for T lymphocyte clonal anergy. Science 1990; 248: 1349-56.
21. Boussiotis VA, Freeman GJ, Gray G, Gribben J, Nadler LM. B7 but not intercellular adhesion molecule-1 costimulation prevents the induction of human alloantigen-specilic tolerance. J. Exp. Med. 1993; 178: 1753-63.
22. Jenkins MK, Taylor PS, Norton SD, Urdhal KB. CD28 delivers a costimulalory signal involved in antigen-specific IL-2 production by human cells. J. Immunol. 1991; 147: 1461-6.
23. Kang S, Beverly B, Tran A, Brorson K, Schwartz RH, Lenardo MJ. Transactivation by AP-1 is a molecular target of T cell clonal anergy. Science 1992; 157: 1134-8.
24. 4 T cells. Science 1996; 271: 1276-8.
25. + T cells. Science 1996; 271: 1272-6.
26. Becker JC, Brabletz T, Kirchner T, Conrad CT, Brocker EB, Reisfeld RA. Negative transcriptional regulation in anergic T cells. Proc. Natl Acad. Sci. USA 1995; 92: 2375-8.
27. Sloan-Lancaster J, Evavold BD, Allen PM. Induction of T cell anergy by altered T-cell receptor ligand on live antigen-presenting cells. Nature 1993; 363: 156-9.
28. + T cells. J. Exp Med. 1996; 184: 19-29.
29. Beverly B, Kang S, Lenardo MJ, Schwartz RH. Reversal of in vitro T cell clonal anergy by IL-2 stimulation. Int. Immunol. 1992; 4: 661-71.
30. Swanborg R, Swierkoz J, Saieg R. Studies on the species variability of experimental allergic encephalomyelitis in guinea pigs and rats. J. Immunol. 1974; 112: 594-600.
31. Ben-Nun A, Wekerle H, Cohen I. The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis. Eur. J. Immunol. 1981; 11: 195-9.
32. + T cell clones in the rat: Cloning methodology and interferon-γ secretion. J. Immunol. Methods 1989; 121: 185-96.
33. Spiess PJ, Rosenberg SA. A simplified method for the production of murine T cell growth factor free of lectin. J. Immunol. Methods 1981; 42: 213-22.
34. Espevik T, Nissen-Meyer J. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J. Immunol. Methods 1986; 95: 99-105.
35. Ramsdell F, Fowlkes B. Maintenance of in vivo tolerance by persistence of antigen. Science 1992; 257: 1130-4.
36. Van Houten N, Blake S. Direct measurement of anergy of antigen-specific T cells following oral tolerance induction. J. Immunol. 1996; 157: 1337-41.
37. Weiner HL, Mackin GA, Matsui M et al. Double-blind pilot trial of oral tolerization with myclin antigens in multiple sclerosis. Science 1993; 259: 1321-4.
38. Hohol MJ, Khoury SJ, Cook SL, Orav EJ, Hafler DA. Weiner HL. Three-year open protocol continuation study of oral tolerization with myelin antigens in multiple sclerosis and design of a phase III pivotal trial. Ann. NY Acad. Sci. 1996; 778: 243-50.
39. Trentham DE, Dynesius-Trentham RA, Orav EJ et al. Effects of oral administration of collagen on rheumatoid arthritis. Science 1996; 261: 1727-30.
40. Barnett ML, Combitichi D, Trentham DE. A pilot trial of oral type II collagen in the treatment of juvenile rheumatoid arthritis. Arthritis Rheum. 1996; 39: 623-38.
41. Sieper J, Kary S, Sorensen H, Alten R et al. Oral type II collagen treatment in early rheumatoid arthritis: A double-blind, placebo-controlled, randomized trial. Arthritis Rheum. 1996; 39: 41-51.
42. Nussenblatt RB, Whitcup SM, de Smet MD et al. Intraocular inflammatory disease (uveitis) and the use of oral tolerance: A status report Ann. NY Acad. Sci. 1996; 778: 325-37.
43. Weiner HL. Oral tolerance: Immune mechanisms and treatment of autoimmune diseases, Immunol. Today 1997; 18: 335-43.
44. Husby S, Mestecky J, Moldoveanu Z, Holland S, Elson EO. Oral tolerance in humans: T cell but not B cell tolerance after antigen feeding. J. Immunol. 1994; 152: 4663-70.
45. Okumura S, McIntosh K, Drachman DB. Oral administration of acetylcholine receptor: Effects on experimental myasthenia gravis. Ann. Neurol. 1994; 36: 704-13.